The ACVD task force on canine atopic dermatitis (XXIV): Allergen-specific immunotherapy

Veterinary Immunology and Immunopathology

Volumn 81, Issue 3-4, 2001, Pages 363-383

  Griffin, Craig E ^a   Hillier, Andrew ^b  

^a Animal Dermatology Clinic   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Allergen specific immunotherapy; Atopic dermatitis; Atopy; Dog; Hyposensitization

Indexed keywords

ALLERGEN;

ATOPIC DERMATITIS; DESENSITIZATION; DOG; DRUG EFFICACY; IMMUNOTHERAPY; INTRACUTANEOUS TEST; NONHUMAN; PRURITUS; REVIEW;

EID: 0035922035     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(01)00348-8     Document Type: Article

References (73)

1. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials
2. Mechanisms of allergen-specific immunotherapy
3. Monoclonal antibody-standardized cat extract immunotherapy: risk benefit effects from a double-blind placebo study
4. Long-term management of atopic disease in the dog
5. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy
6. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy
7. Differences in clinical and immunologic reactivity in patients allergic to grass pollens and allergic to multiple pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts
8. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper
9. Recent developments in the treatment of atopic eczema
10. Remission of life-long atopic dermatitis after hyposensitization to house dust mite
11. Immunotherapy with allergens
12. Specific hyposensitization in atopic dermatitis
13. Effect of humoral tolerance (IgG and IgE) in dogs by oral administration of ovalbumin and Der pI
14. Immunologic changes associated with allergen immunotherapy
15. Suppression of the late cutaneous response by immunotherapy
16. Summer hay fever treated with aqueous and alum-precipitated pyridine extracts
17. Further observation on the treatment of hay fever by hypodermic inoculation of pollen vaccine
18. Some aspects of active immunization
19. The clinical evaluation and the preparation and standardization of suspensions of a new water insoluble whole ragweed complex
20. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema
21. Hyposensitization
22. Atopic disease in the dog
23. A controlled dose response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects
24. Immunotherapy with cat and dog dander extracts. V. Effects of 3 years of treatment
25. Effect of immunotherapy on the serum concentration of allergen-specific IgG antibodies in dog sera
26. The effect of alum concentration on the repository and adjuvant properties of alum-precipitated antigens
27. Effects of immunotherapy on the early, late and rechallenge nasal reaction provocation with allergen: changes in inflammatory mediators and cells
28. Value of hyposensitization therapy for perennial bronchial asthma in children
29. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study
30. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study
31. Antibody response following immunotherapy in ragweed hay fever: allpyral vs. whole ragweed extract
32. A double-blind study of the effectiveness of injection therapy in ragweed hay fever
33. The nasal response to histamine challenge: effect of the pollen season and immunotherapy
34. Position paper: immunotherapy
35. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients
36. Immunotherapy in atopic dermatitis
37. Evaluation of the performance of a serologic allergy system in atopic dogs
38. Long-term immunotherapy of 146 dogs with atopic dermatitis - a retrospective study
39. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis
40. Effect of preservatives and conditions of storage on the potency of allergy extracts
41. Canine allergic inhalant dermatitis: a review of 230 cases
42. Antihistamine premedication in a specific cluster immunotherapy: a double-blind, placebo-controlled study
43. Pilot study of IFN-gamma-induced specific hyposensitization for house dust mites in atopic dermatitis: IFN-gamma-induced deviation as a new therapeutic concept for atopic dermatitis
44. Prophylactic inoculation against hay fever
45. The clinical and immunologic specificity of immunotherapy
46. Retrospective survey of allergen immunotherapy in canine atopy
47. Comparison of response to immunotherapy by intradermal skin test and antigen-specific IgE in canine atopy
48. Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
49. Rush immunotherapy in a dog with severe ragweed and grass pollen allergy
50. Suppression of late-phase skin reactions by immunotherapy with ragweed extract
51. Canine atopy
52. Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins
53. The effects of mold proteases on the biological activity of pollen allergenic extracts in atopic dogs
54. Immunotherapy for canine atopic dermatitis: efficacy in 125 atopic dogs with vaccine formulation based on ELISA allergy testing
55. Observations on canine atopy
56. Advances in methodology for diagnosis of allergic skin disease
57. Allergen immunotherapy: guidelines, update and recommendations of the World Health Organization
58. Treatment of ragweed hay fever with allpyral extracts
59. The use of alum-precipitated pyridine extracted pollen extract in the treatment of ragweed pollinosis
60. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous reactions
61. Effect of hyposensitization on atopic dermatitis in dogs
62. Spontaneous allergy (atopy) in the lower animals. Seasonal hay fever (fall type) in a dog
63. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis